Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 52.01B | 51.12B | 51.62B | 47.65B | 44.03B |
Gross Profit | 5.56B | 5.84B | 5.09B | 5.24B | 4.47B |
EBITDA | 5.23B | 5.28B | 4.42B | 4.74B | 3.97B |
Net Income | 2.21B | 2.27B | 1.77B | 1.95B | 1.50B |
Balance Sheet | |||||
Total Assets | 47.48B | 46.73B | 42.31B | 41.25B | 40.83B |
Cash, Cash Equivalents and Short-Term Investments | 13.95B | 12.24B | 6.71B | 6.17B | 5.51B |
Total Debt | 7.00B | 8.15B | 7.14B | 8.11B | 9.02B |
Total Liabilities | 21.71B | 22.70B | 20.27B | 20.68B | 21.69B |
Stockholders Equity | 25.77B | 24.02B | 22.03B | 20.55B | 19.13B |
Cash Flow | |||||
Free Cash Flow | 2.70B | -208.00M | 2.03B | 2.62B | 2.62B |
Operating Cash Flow | 3.80B | 4.58B | 3.58B | 3.80B | 3.61B |
Investing Cash Flow | -1.13B | -3.14B | -1.25B | -1.94B | -1.01B |
Financing Cash Flow | -1.76B | 610.00M | -1.40B | -1.30B | -1.60B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥12.59B | 11.28 | 4.13% | 2.56% | 168.27% | ||
74 Outperform | ¥6.03B | 12.93 | 2.72% | 4.81% | -6.89% | ||
72 Outperform | ¥18.09B | 7.84 | 2.60% | 1.73% | -2.77% | ||
70 Outperform | ¥7.20B | 7.51 | 3.94% | 1.73% | -61.62% | ||
70 Outperform | ¥23.39B | 9.80 | 3.13% | 3.60% | 16.83% | ||
65 Neutral | $10.94B | 15.63 | 5.18% | 2.37% | 3.14% | -27.13% | |
62 Neutral | ¥3.92B | 36.32 | 1.56% | 0.09% | 76.84% |